This chart shows the probability of a drug’s regulatory approval from the start of phase-1 for various cancer types. The overall success rate in oncology is 4.7%, the lowest rate for any area of drug development.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.